Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Voprosy Onkologii|December 24, 2011
[Use of autofluorescence bronchoscopy and spectrometry in the diagnosis of central lung cancer]A A Barchuk, A I Arsen'ev, E V Levchenko, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2003
Polyglycine II nanosheets: supramolecular antivirals?Alexander B Tuzikov, Alexander A Chinarev, Alexandra S Gambaryan, et al.
Onkologie|May 27, 2010
High efficacy of first-line gefitinib in non-Asian patients with EGFR-mutated lung adenocarcinomaVladimir M Moiseyenko, Svetlana A Procenko, Evgeny V Levchenko, et al.
Sensors (Basel, Switzerland)|February 23, 2016
Tunable Microcavity-Stabilized Quantum Cascade Laser for Mid-IR High-Resolution Spectroscopy and SensingSimone Borri, Mario Siciliani de Cumis, Giacomo Insero, et al.
Molecules (Basel, Switzerland)|August 12, 2022
Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma CellsAlexandr N Chernov, Tatiana A Filatenkova, Ruslan I Glushakov, et al.
Breast Cancer Research and Treatment|November 22, 2014
Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriersWerner Pfeifer, Anna P Sokolenko, Olga N Potapova, et al.
Voprosy Onkologii|April 6, 2010
[Effectiveness of gefitinib (Iressa) as first-line therapy for inoperable non-small-cell lung cancer with mutated EGFR gene (phase II study)]V M Moiseenko, S A Protsenko, I I Semenov, et al.
Voprosy Onkologii|August 15, 2012
[Pharmacoeconomic analysis of gefitinib therapy in patients with non-cell cell lung cancer]S A Protsenko, A V Rudakova, F V Moiseenko, et al.
American Heart Journal|July 11, 2026
Antegrade dissection and re-entry versus retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized studyMaksymilian P Opolski, Mateusz Spiewak, Filip Machaj, et al.
Breast Cancer Research and Treatment|June 8, 2006
CHEK2 1100delC mutation is frequent among Russian breast cancer patientsElena V Chekmariova, Anna P Sokolenko, Konstantin G Buslov, et al.
Pageof 26